TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reducing Cancer Disparities Among Latinos in Texas
Brief Summary: The goal of this research study is to learn if a wellness program can help improve diet and physical activity levels and encourage smoking cessation in Latino individuals who are overweight.


Options:
A: Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Controls; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention
B: Arm Label: Community Health Worker Model; Type: EXPERIMENTAL; Interventions: Behavioral: CARIÑO Project | Arm Label: Enhanced Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: CARIÑO Project; Assigned to Arm(s): Community Health Worker Model | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care
C: Arm Label: Health Education (HE); Type: EXPERIMENTAL; Interventions: Behavioral: Health Education, Behavioral: Questionnaires, Drug: Nicotine Patches | Arm Label: Motivation and Problem Solving (MAPS); Type: EXPERIMENTAL; Interventions: Behavioral: Health Education, Behavioral: Questionnaires, Behavioral: Telephone Counseling Sessions, Drug: Nicotine Patches | Intervention Type: BEHAVIORAL; Name: Health Education; Assigned to Arm(s): Health Education (HE), Motivation and Problem Solving (MAPS) | Intervention Type: BEHAVIORAL; Name: Questionnaires; Assigned to Arm(s): Health Education (HE), Motivation and Problem Solving (MAPS) | Intervention Type: BEHAVIORAL; Name: Telephone Counseling Sessions; Assigned to Arm(s): Motivation and Problem Solving (MAPS) | Intervention Type: DRUG; Name: Nicotine Patches; Assigned to Arm(s): Health Education (HE), Motivation and Problem Solving (MAPS)
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Patient video decision aid & telephone coaching | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Printed educational brochure | Intervention Type: BEHAVIORAL; Name: Patient video decision aid & telephone coaching; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Printed educational brochure; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension
Brief Summary: INSPiRED is a multicenter parallel-group trial comparing usual medical treatment (control group) or usual medical treatment plus renal denervation (intervention). In both groups adherence will be monitored both before randomization and during 36 months of follow-up.


Options:
A: Arm Label: Control group; Type: OTHER; Interventions: Procedure: Renal denervation | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Procedure: Renal denervation | Intervention Type: PROCEDURE; Name: Renal denervation; Assigned to Arm(s): Control group, Intervention group
B: Arm Label: Denervation; Type: EXPERIMENTAL; Interventions: Device: Ardian Symplicity™ Catheter | Intervention Type: DEVICE; Name: Ardian Symplicity™ Catheter; Assigned to Arm(s): Denervation
C: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Symplicity Spyral™ multi-electrode renal denervation system | Arm Label: Sham Procedure; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham Procedure | Intervention Type: DEVICE; Name: Symplicity Spyral™ multi-electrode renal denervation system; Assigned to Arm(s): Renal Denervation | Intervention Type: PROCEDURE; Name: Sham Procedure; Assigned to Arm(s): Sham Procedure
D: Arm Label: renal sympathetic denervation; Type: EXPERIMENTAL; Interventions: Procedure: renal sympathetic denervation, Drug: drug, Procedure: Direct-Current Cardioversion | Arm Label: drug therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: drug | Intervention Type: PROCEDURE; Name: renal sympathetic denervation; Assigned to Arm(s): renal sympathetic denervation | Intervention Type: DRUG; Name: drug; Assigned to Arm(s): drug therapy, renal sympathetic denervation | Intervention Type: PROCEDURE; Name: Direct-Current Cardioversion; Assigned to Arm(s): renal sympathetic denervation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension
Brief Summary: INSPiRED is a multicenter parallel-group trial comparing usual medical treatment (control group) or usual medical treatment plus renal denervation (intervention). In both groups adherence will be monitored both before randomization and during 36 months of follow-up.


Options:
A: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Symplicity Spyral™ multi-electrode renal denervation system | Arm Label: Sham Procedure; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham Procedure | Intervention Type: DEVICE; Name: Symplicity Spyral™ multi-electrode renal denervation system; Assigned to Arm(s): Renal Denervation | Intervention Type: PROCEDURE; Name: Sham Procedure; Assigned to Arm(s): Sham Procedure
B: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Renal denervation with a catheter-based procedure (Symplicity® Catheter System) | Arm Label: Maintenance of Medications; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Renal denervation with a catheter-based procedure (Symplicity® Catheter System); Assigned to Arm(s): Renal Denervation
C: Arm Label: Renal sympathetic denervation; Type: EXPERIMENTAL; Interventions: Device: Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA) | Arm Label: Sham procedure; Type: SHAM_COMPARATOR; Interventions: Other: Sham procedure | Intervention Type: DEVICE; Name: Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA); Assigned to Arm(s): Renal sympathetic denervation | Intervention Type: OTHER; Name: Sham procedure; Assigned to Arm(s): Sham procedure
D: Arm Label: Control group; Type: OTHER; Interventions: Procedure: Renal denervation | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Procedure: Renal denervation | Intervention Type: PROCEDURE; Name: Renal denervation; Assigned to Arm(s): Control group, Intervention group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy: Exploration of Cognitive, Affective, and Physiological Mechanisms
Brief Summary: Persons suffering from chronic pain who are treated with long-term opioid therapy are at risk of misusing prescription opioids and developing opioid addiction. Moreover, long-term use of opioids may result in hyperalgesia, which exacerbates opioid craving and consumption. Mindfulness interventions have been shown reduce chronic pain symptoms, addictive processes, and substance use. The investigators hypothesize that relative to a support group control condition, participation in a novel mindfulness-oriented cognitive intervention, Mindfulness-Oriented Recovery Enhancement (MORE), will result in improved well-being and decreased pain, opioid craving, and opioid misuse behaviors among chronic pain patients receiving opioid therapy.


Options:
A: Arm Label: IIDEA; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Integrated Intervention for Dual Problems and Early Action | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Integrated Intervention for Dual Problems and Early Action; Assigned to Arm(s): IIDEA
B: Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Arm Label: IPGT; Type: EXPERIMENTAL; Interventions: Behavioral: IPGT | Intervention Type: BEHAVIORAL; Name: IPGT; Assigned to Arm(s): IPGT | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual
C: Arm Label: Mindfulness Training for Smokers; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mindfulness Training for Smokers | Arm Label: Interactive Learning for Smokers; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interactive Learning for Smokers | Intervention Type: BEHAVIORAL; Name: Mindfulness Training for Smokers; Assigned to Arm(s): Mindfulness Training for Smokers | Intervention Type: BEHAVIORAL; Name: Interactive Learning for Smokers; Assigned to Arm(s): Interactive Learning for Smokers
D: Arm Label: Mindfulness-Oriented Recovery Enhancement; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-Oriented Recovery Enhancement | Arm Label: Conventional Support Group (SG); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional Support Group (SG) | Intervention Type: BEHAVIORAL; Name: Mindfulness-Oriented Recovery Enhancement; Assigned to Arm(s): Mindfulness-Oriented Recovery Enhancement | Intervention Type: BEHAVIORAL; Name: Conventional Support Group (SG); Assigned to Arm(s): Conventional Support Group (SG)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Oral Administration of a Probiotic Strain to Pregnant Women: Effects on the Prevention of Lactational Mastitis and on the Eradication of GBS Colonization
Brief Summary: In previous studies, the investigators have seen that carefully-selected Lactobacillus strains are a good alternative to antibiotics for the treatment of lactational mastitis. The objective of this new study is to check if they can also have a preventive role when administered to women with a history of mastitis with one or more previous infants. Since the investigators have also realized that peripartum antibiotherapy (mainly GBS-targeting intrapartum prophylaxis)is a predisposing factor for mastitis (because of the selection of resistant bacteria), the investigators would also like to test if administration of the strains to GBS-colonized pregnant women may lead to GBS eradication. Therefore, a mastitis-predisposing factor would de avoid.


Options:
A: Arm Label: probiotics & allergy; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus rhamnosus GG | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus rhamnosus GG; Assigned to Arm(s): probiotics & allergy
B: Arm Label: Probiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus rhamnosus GR-1 | Arm Label: Milk; Type: OTHER; Interventions: Dietary Supplement: Pasteurized Whole Milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Pasteurized Whole Milk; Assigned to Arm(s): Milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus rhamnosus GR-1; Assigned to Arm(s): Probiotic
C: Arm Label: Probiotic; Type: EXPERIMENTAL; Interventions: Biological: Lactobacillus salivarius PS2 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Excipient (milk powder) | Intervention Type: BIOLOGICAL; Name: Lactobacillus salivarius PS2; Assigned to Arm(s): Probiotic | Intervention Type: BIOLOGICAL; Name: Excipient (milk powder); Assigned to Arm(s): Placebo
D: Arm Label: Probiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotics | Arm Label: Probiotics + Dietary counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and probiotics | Arm Label: Dietary counseling + placebo; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and placebo | Arm Label: Prebiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Prebiotics | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo capsules | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary counselling and placebo; Assigned to Arm(s): Dietary counseling + placebo | Intervention Type: BEHAVIORAL; Name: Dietary counselling and probiotics; Assigned to Arm(s): Probiotics + Dietary counseling | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo capsules; Assigned to Arm(s): Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotics; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Prebiotics; Assigned to Arm(s): Prebiotics

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea: Double Blinded, Randomized, Placebo Drug Controlled, Parallel Designed, Multi-centered, Phase 2 Study
Brief Summary: The purpose of this study is to Evaluate the Optimal Dosage of Mosapride (Medirac) and Probitics in Irritable Bowel Syndrome Without Predominant Diarrhea.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Saccharomyces cerevisiae CNCM I-3856; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Saccharomyces cerevisiae CNCM I-3856 | Intervention Type: DIETARY_SUPPLEMENT; Name: Saccharomyces cerevisiae CNCM I-3856; Assigned to Arm(s): Saccharomyces cerevisiae CNCM I-3856 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Probiotics(Medirac) 10/mosapride 10mg; Type: EXPERIMENTAL; Interventions: Drug: Probiotics (Medirac) | Arm Label: Probiotics(Medirac) 15/mosapride 10mg; Type: EXPERIMENTAL; Interventions: Drug: Probiotics (Medirac) | Arm Label: Probiotics(Medirac) 15/mosapride 15mg; Type: EXPERIMENTAL; Interventions: Drug: Probiotics (Medirac) | Arm Label: Probiotics(Medirac) 30/mosapride 15mg; Type: EXPERIMENTAL; Interventions: Drug: Probiotics (Medirac) | Arm Label: Probiotics(Medirac) placebo/mosapride placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Probiotics (Medirac) placebo/mosapride placebo | Intervention Type: DRUG; Name: Probiotics (Medirac); Assigned to Arm(s): Probiotics(Medirac) 10/mosapride 10mg | Intervention Type: DRUG; Name: Probiotics (Medirac); Assigned to Arm(s): Probiotics(Medirac) 15/mosapride 10mg | Intervention Type: DRUG; Name: Probiotics (Medirac); Assigned to Arm(s): Probiotics(Medirac) 15/mosapride 15mg | Intervention Type: DRUG; Name: Probiotics (Medirac); Assigned to Arm(s): Probiotics(Medirac) 30/mosapride 15mg | Intervention Type: DRUG; Name: Probiotics (Medirac) placebo/mosapride placebo; Assigned to Arm(s): Probiotics(Medirac) placebo/mosapride placebo
C: Arm Label: Probiotics supplementation; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotics | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotics; Assigned to Arm(s): Probiotics supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Mixture of three Bifidobacteria; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mixture of three Bifidobacteria | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Mixture of three Bifidobacteria | Intervention Type: DRUG; Name: Mixture of three Bifidobacteria; Assigned to Arm(s): Mixture of three Bifidobacteria, Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Long Term Safety of the Use of Dabigatran Etexilate in Patients With a Bileaflet Mechanical Heart Valve
Brief Summary: To collect additional data relating to safety and indicators of efficacy for patients who have participated in the 1160.113 study.


Options:
A: Intervention Type: DRUG; Name: SR34006 (idraparinux sodium) Injection; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: vitamin K antagonist (warfarin or acenocoumarol) tablets; Assigned to Arm(s): N/A
B: Arm Label: Dabigatran dose 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dabigatran dose 2 | Arm Label: Warfarin; Type: ACTIVE_COMPARATOR; Interventions: Drug: warfarin | Arm Label: Dabigatran dose 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dabigatran dose 1 | Intervention Type: DRUG; Name: warfarin; Assigned to Arm(s): Warfarin | Intervention Type: DRUG; Name: Dabigatran dose 1; Assigned to Arm(s): Dabigatran dose 1 | Intervention Type: DRUG; Name: Dabigatran dose 2; Assigned to Arm(s): Dabigatran dose 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: AZD0837 | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: AZD0837 | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: AZD0837 | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Drug: AZD0837 | Arm Label: 5; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin-K antagonist at INR 2-3 | Intervention Type: DRUG; Name: AZD0837; Assigned to Arm(s): 1, 3, 4 | Intervention Type: DRUG; Name: Vitamin-K antagonist at INR 2-3; Assigned to Arm(s): 5 | Intervention Type: DRUG; Name: AZD0837; Assigned to Arm(s): 2
D: Arm Label: Dabigatran etexilate; Type: EXPERIMENTAL; Interventions: Drug: dabigatran etexilate low dose, Drug: dabigatran etexilate intermediate dose, Drug: dabigatran etexilate high dose | Arm Label: warfarin; Type: ACTIVE_COMPARATOR; Interventions: Drug: warfarin 5mg, Drug: warfarin 1mg, Drug: warfarin 3mg | Intervention Type: DRUG; Name: dabigatran etexilate low dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: warfarin 5mg; Assigned to Arm(s): warfarin | Intervention Type: DRUG; Name: dabigatran etexilate intermediate dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: warfarin 1mg; Assigned to Arm(s): warfarin | Intervention Type: DRUG; Name: dabigatran etexilate high dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: warfarin 3mg; Assigned to Arm(s): warfarin

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Long Term Safety of the Use of Dabigatran Etexilate in Patients With a Bileaflet Mechanical Heart Valve
Brief Summary: To collect additional data relating to safety and indicators of efficacy for patients who have participated in the 1160.113 study.


Options:
A: Arm Label: Dabigatran etexilate; Type: EXPERIMENTAL; Interventions: Drug: dabigatran etexilate intermediate dose, Drug: dabigatran etexilate low dose, Drug: dabigatran etexilate high dose | Arm Label: warfarin; Type: ACTIVE_COMPARATOR; Interventions: Drug: warfarin 1mg, Drug: warfarin 5mg, Drug: warfarin 3mg | Intervention Type: DRUG; Name: warfarin 1mg; Assigned to Arm(s): warfarin | Intervention Type: DRUG; Name: dabigatran etexilate intermediate dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: dabigatran etexilate low dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: warfarin 5mg; Assigned to Arm(s): warfarin | Intervention Type: DRUG; Name: dabigatran etexilate high dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: warfarin 3mg; Assigned to Arm(s): warfarin
B: Arm Label: Dabigatran etexilate; Type: EXPERIMENTAL; Interventions: Drug: dabigatran etexilate low dose, Drug: dabigatran etexilate intermediate dose, Drug: dabigatran etexilate high dose | Arm Label: warfarin; Type: ACTIVE_COMPARATOR; Interventions: Drug: warfarin 5mg, Drug: warfarin 1mg, Drug: warfarin 3mg | Intervention Type: DRUG; Name: dabigatran etexilate low dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: warfarin 5mg; Assigned to Arm(s): warfarin | Intervention Type: DRUG; Name: dabigatran etexilate intermediate dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: warfarin 1mg; Assigned to Arm(s): warfarin | Intervention Type: DRUG; Name: dabigatran etexilate high dose; Assigned to Arm(s): Dabigatran etexilate | Intervention Type: DRUG; Name: warfarin 3mg; Assigned to Arm(s): warfarin
C: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Self-management; Type: EXPERIMENTAL; Interventions: Other: Self-monitoring and adjustment of oral anticoagulation | Intervention Type: OTHER; Name: Self-monitoring and adjustment of oral anticoagulation; Assigned to Arm(s): Self-management
D: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Drug: Warfarin | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Drug: Warfarin | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Group B

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Comparative Trial on the Efficacy of Behavioral Therapy, Exercise and Their Combination in Gestational Diabetes Mellitus (GDM).
Brief Summary: The purpose of the study is to test whether four lifestyle intervention programs (diet alone; diet and behavioral therapy, diet and exercise, diet and behavioral therapy and exercise), delivered to women with GDM during 24-26 weeks of gestational age will help women to improve their metabolic pattern, and decrease the incidence of adverse maternal and neonatal outcomes.


Options:
A: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: Wait-listed control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): intervention
B: Arm Label: Diet alone; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Behavioral therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral therapy | Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Other: Exercise | Arm Label: Behavioral therapy and exercise; Type: EXPERIMENTAL; Interventions: Other: Behavioral therapy and exercise | Intervention Type: BEHAVIORAL; Name: Behavioral therapy; Assigned to Arm(s): Behavioral therapy | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise | Intervention Type: OTHER; Name: Behavioral therapy and exercise; Assigned to Arm(s): Behavioral therapy and exercise
C: Arm Label: Heath & Wellness; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Heath & Wellness | Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): Exercise | Intervention Type: BEHAVIORAL; Name: Heath & Wellness; Assigned to Arm(s): Heath & Wellness
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Aquatic exercise; Type: EXPERIMENTAL; Interventions: Other: Aquatic exercise | Intervention Type: OTHER; Name: Aquatic exercise; Assigned to Arm(s): Aquatic exercise

Answer: B